Endothelial Progenitor Cells in Tumor Angiogenesis: Another Brick in the Wall

Imagem de Miniatura
Arquivos
art_MARCOLA_Endothelial_Progenitor_Cells_in_Tumor_Angiogenesis_Another_Brick_2015.PDF (1.43 MB)
Citações na Scopus
68
Tipo de produção
article
Data de publicação
2015
Editora
HINDAWI PUBLISHING CORPORATION
DOI
Indexadores
Scopus
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Autores
MARCOLA, Marina
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
STEM CELLS INTERNATIONAL, article ID 832649, 10p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Until 15 years ago, vasculogenesis, the formation of new blood vessels from undifferentiated cells, was thought to occur only during embryonic development. The discovery of circulating cells that are able to promote vascular regeneration and repair-the so-called endothelial progenitor cells (EPCs)-changed that, and EPCs have since been studied extensively. It is already known that EPCs include many subtypes of cells that play a variety of roles in promoting vascular growth. Some EPCs are destined to differentiate into endothelial cells, whereas others are capable of promoting and sustaining angiogenesis through paracrine mechanisms. Vasculogenesis and angiogenesis might constitute complementary mechanisms for postnatal neovascularization, and EPCs could be at the core of this process. Although the formation of new blood vessels from preexisting vasculature plays a beneficial role in many physiological processes, such as wound healing, it also contributes to tumor growth and metastasis. However, many aspects of the role played by EPCs in tumor angiogenesis remain unclear. This review aims to address the main aspects of EPCs differentiation and certain characteristics of their main function, especially in tumor angiogenesis, as well as the potential clinical applications.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/10000
Referências
  1. Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073
  2. Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
  3. Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003
  4. Asahara T, 1999, CIRC RES, V85, P221
  5. AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8
  6. Balaji S., 2013, ADV WOUND CARE NEW R, V2, P283
  7. Bandello F, 2012, OPHTHALMIC RES, V48, P16, DOI 10.1159/000339843
  8. Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525
  9. Bertolini Francesco, 2006, Nat Rev Cancer, V6, P835, DOI 10.1038/nrc1971
  10. Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770
  11. Bowers SLK, 2015, METHODS MOL BIOL, V1189, P171, DOI 10.1007/978-1-4939-1164-6_12
  12. Bu XF, 2010, J SURG RES, V164, P50, DOI 10.1016/j.jss.2009.03.018
  13. Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002
  14. Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
  15. Chironi G, 2007, ATHEROSCLEROSIS, V191, P115, DOI 10.1016/j.atherosclerosis.2006.02.041
  16. Choi JH, 2014, MOL CELLS, V37, P487, DOI 10.14348/molcells.2014.0119
  17. Claesson-Welsh L, 2008, ARTERIOSCL THROM VAS, V28, P1575, DOI 10.1161/ATVBAHA.108.170878
  18. Deeb KK, 2011, EPIGENETICS-US, V6, P994, DOI 10.4161/epi.6.8.16536
  19. de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462
  20. DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256
  21. Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88
  22. Fitsialos G, 2008, J CELL SCI, V121, P2992, DOI 10.1242/jcs.029256
  23. FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
  24. Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064
  25. GLEAVE ME, 1993, CANCER RES, V53, P5300
  26. Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607
  27. Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
  28. Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
  29. Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21
  30. Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
  31. Hirschi KK, 2002, GENE THER, V9, P648, DOI 10.1038/sj/gt/3301722
  32. Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
  33. Hwang HS, 2008, ACTA OBSTET GYN SCAN, V87, P643, DOI 10.1080/00016340802085326
  34. Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
  35. Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
  36. KASSMEYER S, 2009, J VET MED C, V38, P1
  37. Kim J, 2013, BIOMATERIALS, V34, P1669, DOI 10.1016/j.biomaterials.2012.11.017
  38. Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33
  39. Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
  40. Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283
  41. Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205
  42. Kryczek I, 2005, CANCER RES, V65, P465
  43. Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015
  44. Laurenzana A, 2014, ONCOTARGET, V5, P3711
  45. Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y
  46. Lin JL, 2008, FEBS LETT, V582, P2615, DOI 10.1016/j.febslet.2008.06.033
  47. Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
  48. Ling CC, 2014, J HEPATOL, V60, P103, DOI 10.1016/j.jhep.2013.08.017
  49. Liu JF, 2014, EXP THER MED, V8, P805, DOI 10.3892/etm.2014.1827
  50. Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5
  51. Melero-Martin JM, 2011, STEM CELLS, V29, P163, DOI 10.1002/stem.583
  52. Neufeld G, 2002, ADV EXP MED BIOL, V515, P81
  53. NICOSIA RF, 1994, AM J PATHOL, V145, P1023
  54. Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307
  55. Oberlin E, 2002, DEVELOPMENT, V129, P4147
  56. Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263
  57. Okamoto OK, 2009, EXPERT REV MOL DIAGN, V9, P545, DOI [10.1586/erm.09.40, 10.1586/ERM.09.40]
  58. PEPPER MS, 1993, EXP CELL RES, V204, P356, DOI 10.1006/excr.1993.1043
  59. Petersen W, 2005, ANN ANAT, V187, P509, DOI 10.1016/j.aanat.2005.04.010
  60. Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305
  61. Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559
  62. Purwanti YI, 2014, STEM CELL TRANSL MED, V3, P923, DOI 10.5966/sctm.2013-0140
  63. Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
  64. Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
  65. Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615
  66. Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327
  67. RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1
  68. Russell JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-177
  69. Saif Muhammad Wasif, 2013, Cancer Manag Res, V5, P103, DOI 10.2147/CMAR.S45193
  70. Sakurai A, 2012, CELL RES, V22, P23, DOI 10.1038/cr.2011.198
  71. Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09
  72. Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340
  73. Sepulveda P, 2007, TRANSPL P, V39, P2089, DOI 10.1016/j.transproceed.2007.07.009
  74. Shi Q, 1998, BLOOD, V92, P362
  75. Shih Y. T., 2014, GUT
  76. Shinkaruk S., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P95, DOI 10.2174/1568011033353452
  77. Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661
  78. Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6
  79. Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
  80. Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A
  81. Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768
  82. Takahashi Y, 1996, J NATL CANCER I, V88, P1146, DOI 10.1093/jnci/88.16.1146
  83. Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418
  84. Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972
  85. Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x
  86. Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003
  87. Vartanian KB, 2009, J BIOMED MATER RES A, V91A, P528, DOI 10.1002/jbm.a.32225
  88. Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
  89. Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327
  90. Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006
  91. Watson AR, 2010, J PATHOL, V220, P435, DOI 10.1002/path.2660
  92. Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814
  93. Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79
  94. Williamson K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00030
  95. Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108
  96. Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
  97. Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433
  98. Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928
  99. Zetter BR, 1998, ANNU REV MED, V49, P407
  100. Zhang JX, 2010, ONCOLOGY-BASEL, V78, P94, DOI 10.1159/000306138
  101. Zhang Q., 2013, STEM CELLS INT, V2013

Coleções
Artigos e Materiais de Revistas Científicas - LIM/12
Artigos e Materiais de Revistas Científicas - ODS/03